[go: up one dir, main page]

HRP20120466T1 - Derivati indol ona disupstituirani na položaju njihovo dobivanje i upotreba u terapiji - Google Patents

Derivati indol ona disupstituirani na položaju njihovo dobivanje i upotreba u terapiji Download PDF

Info

Publication number
HRP20120466T1
HRP20120466T1 HRP20120466AT HRP20120466T HRP20120466T1 HR P20120466 T1 HRP20120466 T1 HR P20120466T1 HR P20120466A T HRP20120466A T HR P20120466AT HR P20120466 T HRP20120466 T HR P20120466T HR P20120466 T1 HRP20120466 T1 HR P20120466T1
Authority
HR
Croatia
Prior art keywords
compound
alkyl
general formula
image
group
Prior art date
Application number
HRP20120466AT
Other languages
English (en)
Croatian (hr)
Inventor
Marco@Baroni
Letizia@Puleo
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of HRP20120466T1 publication Critical patent/HRP20120466T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20120466AT 2007-08-16 2008-08-14 Derivati indol ona disupstituirani na položaju njihovo dobivanje i upotreba u terapiji HRP20120466T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705858A FR2920023B1 (fr) 2007-08-16 2007-08-16 Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique
PCT/FR2008/001190 WO2009056707A2 (fr) 2007-08-16 2008-08-14 Dérivés de l'ind0l-2-0ne disubstitues en 3, leur preparation et leur application en thérapeutique

Publications (1)

Publication Number Publication Date
HRP20120466T1 true HRP20120466T1 (hr) 2012-07-31

Family

ID=39197313

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20120466AT HRP20120466T1 (hr) 2007-08-16 2008-08-14 Derivati indol ona disupstituirani na položaju njihovo dobivanje i upotreba u terapiji

Country Status (42)

Country Link
US (2) US20100210662A1 (es)
EP (1) EP2188253B8 (es)
JP (1) JP5685440B2 (es)
KR (1) KR20100051812A (es)
CN (1) CN103443076B (es)
AR (1) AR067937A1 (es)
AT (1) ATE548349T1 (es)
AU (1) AU2008320718B2 (es)
BR (1) BRPI0815171A2 (es)
CA (1) CA2696237C (es)
CO (1) CO6251363A2 (es)
CR (1) CR11273A (es)
CY (1) CY1112809T1 (es)
DK (1) DK2188253T3 (es)
DO (1) DOP2010000050A (es)
EA (1) EA019486B1 (es)
EC (1) ECSP109961A (es)
ES (1) ES2384080T3 (es)
FR (1) FR2920023B1 (es)
GT (1) GT201000032A (es)
HN (1) HN2010000330A (es)
HR (1) HRP20120466T1 (es)
IL (1) IL203956A (es)
JO (1) JO2749B1 (es)
MA (1) MA31742B1 (es)
ME (1) ME00979B (es)
MX (1) MX2010001851A (es)
MY (1) MY149649A (es)
NI (1) NI201000023A (es)
NZ (1) NZ583317A (es)
PA (1) PA8793101A1 (es)
PE (1) PE20090988A1 (es)
PL (1) PL2188253T3 (es)
PT (1) PT2188253E (es)
RS (1) RS52321B (es)
SI (1) SI2188253T1 (es)
TN (1) TN2010000025A1 (es)
TW (1) TWI432423B (es)
UA (1) UA101162C2 (es)
UY (1) UY31297A1 (es)
WO (1) WO2009056707A2 (es)
ZA (1) ZA201001085B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008002427A1 (es) 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
FR2941947B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
FR2941946B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique
EP3711751A1 (en) 2009-02-13 2020-09-23 Boehringer Ingelheim International GmbH Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
CN108658836B (zh) * 2018-05-15 2021-04-20 宁波大学 一种3-取代-3-叠氮基吲哚-2-酮类化合物的制备方法
EP3912625A1 (en) * 2020-05-20 2021-11-24 Kaerus Bioscience Limited Novel maxi-k potassium channel openers for the treatment of fragile x associated disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714378B1 (fr) * 1993-12-24 1996-03-15 Sanofi Sa Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
CN1161333C (zh) * 1998-08-20 2004-08-11 住友制药株式会社 作为生长激素释放剂的2-羟基吲哚衍生物
FR2827604B1 (fr) * 2001-07-17 2003-09-19 Sanofi Synthelabo Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
WO2005035498A1 (ja) * 2003-10-08 2005-04-21 Dainippon Sumitomo Pharma Co., Ltd. 含窒素二環性化合物の摂食調節剤としての用途

Also Published As

Publication number Publication date
CR11273A (es) 2010-07-16
JP5685440B2 (ja) 2015-03-18
FR2920023B1 (fr) 2013-02-08
WO2009056707A8 (fr) 2010-03-18
WO2009056707A2 (fr) 2009-05-07
CN103443076B (zh) 2016-06-22
US8202871B2 (en) 2012-06-19
EP2188253A2 (fr) 2010-05-26
TN2010000025A1 (fr) 2011-09-26
CA2696237A1 (fr) 2009-05-07
FR2920023A1 (fr) 2009-02-20
CN103443076A (zh) 2013-12-11
ES2384080T3 (es) 2012-06-29
EA019486B1 (ru) 2014-04-30
GT201000032A (es) 2012-03-12
EP2188253B8 (fr) 2012-04-11
UA101162C2 (ru) 2013-03-11
SI2188253T1 (sl) 2012-09-28
US20110118280A1 (en) 2011-05-19
DK2188253T3 (da) 2012-07-02
NZ583317A (en) 2011-11-25
DOP2010000050A (es) 2010-04-15
PL2188253T3 (pl) 2012-08-31
PA8793101A1 (es) 2009-01-23
WO2009056707A3 (fr) 2009-10-01
ECSP109961A (es) 2010-03-31
ME00979B (me) 2012-06-20
IL203956A (en) 2014-06-30
NI201000023A (es) 2010-03-11
KR20100051812A (ko) 2010-05-18
ATE548349T1 (de) 2012-03-15
JP2010536736A (ja) 2010-12-02
CY1112809T1 (el) 2016-02-10
MX2010001851A (es) 2010-03-11
US20100210662A1 (en) 2010-08-19
UY31297A1 (es) 2009-03-31
PT2188253E (pt) 2012-05-11
EP2188253B1 (fr) 2012-03-07
MY149649A (en) 2013-09-30
ZA201001085B (en) 2011-04-28
RS52321B (en) 2012-12-31
EA201070281A1 (ru) 2010-08-30
AU2008320718B2 (en) 2013-09-19
AU2008320718A1 (en) 2009-05-07
CO6251363A2 (es) 2011-02-21
MA31742B1 (fr) 2010-10-01
PE20090988A1 (es) 2009-08-14
JO2749B1 (en) 2014-03-15
HN2010000330A (es) 2012-03-19
TW200914438A (en) 2009-04-01
BRPI0815171A2 (pt) 2015-03-31
TWI432423B (zh) 2014-04-01
CA2696237C (fr) 2016-07-05
AR067937A1 (es) 2009-10-28

Similar Documents

Publication Publication Date Title
HRP20120466T1 (hr) Derivati indol ona disupstituirani na položaju njihovo dobivanje i upotreba u terapiji
RU2345070C2 (ru) Производные аминоиндазолов в качестве лекарственных средств, способ их получения и содержащие их фармацевтические композиции
JP4693787B2 (ja) Ｃｂ１拮抗活性を有する１，３，５−三置換４，５−ジヒドロ−１ｈ−ピラゾール誘導体
RU2299200C2 (ru) Производные 1н-имидазола, обладающие cb1-агонистической, частичной cb1-агонистической или cb1-антагонистической активностью
CA2456606C (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
AU2004287245B2 (en) Use of CRTH2 antagonist compounds in therapy
CA2362381A1 (en) Amide compounds and medicinal use thereof
JPH04270264A (ja) セロトニン５ｈｔ▲１ａ▼アゴニスト
CA2601980A1 (en) 1-acetic acid-indole derivatives with pgd2 antagonist activity
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
WO2002012189A1 (fr) Composes amide bicycliques condenses et utilisations medicales associees
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
YU96103A (sh) Novi derivati indola sa afinitetom za 5-ht6 receptor
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
HRP20130004T1 (hr) 4-supstituirani derivati fenoksifeniloctene kiseline
HUP0400343A2 (hu) Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
JP2008542365A5 (es)
RU2005117783A (ru) 1, 5-диарилпиррол-3-карбоксамидные производные и их применение в качестве модуляторов каннабиноидных рецепторов
RU2007136783A (ru) ГИДРАЗИНОКАРБОНИЛТИЕНО[2, 3-c]ПИРАЗОЛЫ, СПОСОБ ПОЛУЧЕНИЯ, СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ
RU2007106180A (ru) Производные индола, индазола или индолина
JPH02290849A (ja) テトラヒドロベンゾ［ｃ，ｄ］インドール・セロトニン作動薬
JP2005527521A5 (es)
ZA200304913B (en) Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient.
RU2006122935A (ru) Новые производные бензимидазола и имидазопиридина и их применение в качестве лекарственных средств
JP2017516824A5 (es)